| Concomitant |
| Product Used For Unknown Indication |
15.6% |
| Hypertension |
12.8% |
| Drug Use For Unknown Indication |
10.7% |
| Dizziness |
10.3% |
| Depression |
4.3% |
| Prophylaxis |
4.1% |
| Constipation |
4.0% |
| Insomnia |
4.0% |
| Pain |
4.0% |
| Hepatitis C |
3.8% |
| Asthenopia |
3.5% |
| Gastric Ulcer |
3.4% |
| Gastritis |
3.3% |
| Diabetes Mellitus |
3.1% |
| Pancreatic Neuroendocrine Tumour |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Cerebral Infarction |
2.1% |
| Arteriosclerosis Obliterans |
2.0% |
| Psoriasis |
2.0% |
| Atrial Fibrillation |
1.9% |
|
| Vomiting |
15.9% |
| Renal Failure Acute |
12.5% |
| Rhabdomyolysis |
6.8% |
| Cerebral Infarction |
5.7% |
| Pneumonia Aspiration |
5.7% |
| Hyperammonaemia |
4.5% |
| Interstitial Lung Disease |
4.5% |
| Renal Impairment |
4.5% |
| Stomatitis |
4.5% |
| Tremor |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Blood Potassium Decreased |
3.4% |
| Hallucination, Visual |
3.4% |
| Optic Neuritis |
3.4% |
| Therapeutic Agent Toxicity |
3.4% |
| Urine Output Decreased |
3.4% |
| Altered State Of Consciousness |
2.3% |
| Atrial Fibrillation |
2.3% |
| Dehydration |
2.3% |
| Drug Eruption |
2.3% |
|
